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Abstract 
HYDROXOCOBALAMIN TREATMENT FOR CARBON MONOXIDE 
EXPOSURES: CHARACTERIZING CARBOXYHEMOGLOBIN CHANGES 
AND TESTING FOR NEUROLOGICAL SEQUELAE 
 
 By Leonardo Gamueda Somera, III, B.S. 
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University. 
 
Virginia Commonwealth University, 2014 
 
Major Advisor: Bruce D. Spiess, MD, FAHA 
Professor, Department of Anesthesiology 
Affiliate Professor, Department of Biology 
 Prior work in our lab has indicated that reduced Hydroxocobalamin (B12r) can be added to 
human blood and is able to convert carbon monoxide (CO) into carbon dioxide. This has great 
potential as a direct antidote to mitigate the toxic effects of CO poisoning which is a public 
health risk. In the first part of our work, we use highly specific wavelengths of light and Raman 
spectroscopy to study changes in carboxyhemoglobin (COHb) between blood treated with 
oxygen and blood treated with oxygen and B12r in a flowing circuit of blood. Using Raman 
spectroscopy, we found that the addition of B12r hastens the conversion of the COHb Raman 
signals to oxyhemoglobin (HbO2) Raman signals. In addition, the B12r absorbance of light 
energy within the Raman spectrum is an exploitable relationship that can be used to measure 
B12r presence in the blood. In part two of our study we focused on the neurobehavioral testing of 
rats injured by CO exposure, however, we were not able to find statistical differences in the 
behavioral tests between exposed and unexposed rats.
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Introduction 
Carbon Monoxide Exposure and Toxicity 
 Carbon Monoxide (CO) results from the incomplete combustion of carbon materials due to 
inadequate concentrations of available O2 to facilitate full oxidation of carbon into CO2.  
Common sources of concern for CO are structure fires, poorly ventilated or malfunctioning gas 
heaters or stoves, exhaust from fuel combustion vehicles and generators.  Inhalation exposures 
are a common public health concern resulting in over 15,000 exposures and 500 deaths per year 
for non-fire incidents alone.1   Exposures are known to cause acute neurological sequelae and 
delayed neurological sequelae (DNS) in about 10% of victims.2–5  Neurological sequelae, or 
encephalopathy, manifests as impaired cognitive behaviors. Generally, it is due to injury or 
disease of the nervous system. In CO injury, this may last hours or days depending on the 
severity of exposure.  In humans, the encephalopathy typically associated with CO exposure is 
dizziness, confusion, memory loss, disorientation, difficulty in coordinating, and loss of 
consciousness.4,5  DNS due to CO exposures occurs days to weeks later and may reappear after 
recovery from the initial encephalopathy.  DNS symptoms associated with CO exposures include 
memory disturbances, depression, anxiety, personality changes, deficiencies in higher cognitive 
abilities, as well as motor dysfunctions.  DNS can be a chronic, unyielding condition. The 
complex mechanism for neurological sequelae from inhalation exposure starts with CO transport 
via the circulatory system to affect the nervous system at the cellular level.  Classically, hypoxia-
induced toxicity due to CO binding hemoglobin (Hb) to form carboxyhemoglobin (COHb) has 
been the primary explanation of encephalopathy.  More recent discoveries show the relationship 
to be more complex with CO binding to proteins such as guanylyl cyclase, cytochrome c, and 
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perhaps signaling molecules.  The effects of guanylyl binding by CO lead to cerebral 
vasodilation potentially with loss of consciousness. The binding of cytochrome c impairs cellular 
metabolic pathways affecting the production of essential energy.6  Studies in this field continue 
to show CO directly affecting normal cellular functions. DNS’s longer evolution time led to 
evidence that DNS may have immune-mediated mechanisms on rats. The study showed an 
immune signature alteration of myelin causing an autoimmune reaction with neural tissue after 
exposure to CO.3 
The treatment for victims of CO exposure is breathing 100% O2 up to several hours to provide 
oxygen delivery. CO removal is a secondary effect of the treatment. This treatment reduces the 
body’s half-life of CO from 5-8 hours down to 1-2 hours. In more severe cases, and if the 
capability is present, administration of O2 is conducted in a hyperbaric chamber at 1.5 to 2 
atmospheres.  Even with hyperbaric capabilities, the treatment can take hours to remove 
sufficient CO; treatment that seems to have the best outcomes involves rotating between normal 
pressure O2 and hyperbaric O2 in a 48-hour treatment.
5,7  At the time of this study, there were no 
treatments that directly removed CO from the body. 
Here we study the first intravenous antidote to directly affect CO. The treatment, B12r, is a 
reduced form of Vitamin B12, or Hydroxocobalamin (OHCbl), that catalyzes a conversion of CO 
to CO2 thus removing the CO toxicity threat directly.
8,9  This injectable treatment should be 
faster and more efficient than ventilation with 100% O2 alone.  It could be combined with 
oxygen delivery therapies to enhance removal of CO. 
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Hemoglobin and Gas Transport 
 In this study, blood refers to whole human blood obtained from donors.  Hemoglobin-bound 
O2 accounts for 98% of the O2 content in blood, and the remaining 2% is dissolved in plasma and 
the intracellular fluid of red blood cells.  Similar to O2, CO is transported between the lungs and 
tissues via the circulatory system. CO is also primarily transported bound to hemoglobin.  Less 
than 1% may be found freely dissolved in plasma or interstitial fluid.10  Hemoglobin, a globular 
protein, has two alpha-chain and two beta-chain subunits.  Each of the four subunits contain a 
single porphyrin ring with an iron center that can bind O2 or CO.  Hemoglobin with iron in the 
ferrous state (Fe2+) can bind to O2 and CO.  Methemoglobin contains iron in the ferric state 
(Fe3+) and cannot bind either O2 or CO.  Deoxyhemoglobin is ferrous hemoglobin unbound to 
any gas molecule.11 
 As hemoglobin changes from one form to another, its spectral absorption properties change.  
When blood is exposed to oxygen, a bright red color is observed; with nitrogen gas, a dark red 
appears as Deoxyhemoglobin forms.  Absorption spectroscopy has been used in clinical settings 
to measure percentages of various hemoglobin forms and calculate oxygen saturation—vital 
metrics to diagnose the status of a patient.  Blood/Gas machines used in clinical settings contain 
absorption-spectroscopy technology to measure relative amounts of hemoglobin forms.  Some 
pharmaceutical treatments, however, interfere with the machines’ abilities to differentiate 
absorption spectra due to the treatments’ pigment similarities to Hb. Cyanokit™, a B12 treatment 
for cyanide poisoning is one, and the proposed B12 treatment in this study, naturally, would be 
another. Raman spectroscopy is used in this study to overcome this interference. 
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B12r: a Potential Carbon Monoxide Exposure Treatment 
Due to the long half-life of CO in the body, blood can continue to deliver CO to tissue and 
organs for several hours even after removal of the victim from the site of exposure.  Elimination 
of the CO benefits victims.  B12r, a reduced form of Hydroxocobalamin (B12), may catalyze the 
conversion of CO to CO2.8,9  We propose that an injection of B12r into the circulatory system 
may enhance elimination of CO from the blood and block delivery to tissues. 
B12 consists of a corrinoid ring with a cobalt center resembling a porphyrin ring.   The core 
molecular structure of B12 resembles the heme ring of a hemoglobin subunit.  Figure 1 below 
shows the B12 moiety, Hydroxocobalamin, alongside a porphyrin ring with an iron center (Heme 
B).   
  
Figure 1 - Hydroxocobalamin (Vit B12 moiety) on the left and Heme B on the right.  This shows 
structural similarities between the two molecules. 
Buffered ascorbic acid (AA), was used to reduce the B12 to B12r.8  This reduction modifies 
the Cobalt center from Co+3 to Co+2 and thus making it reactive to CO.  Raman spectroscopy was 
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used to validate the reduction of B12r with AA (Figure 8). The Raman spectra of reduced and 
unreduced B12 are well documented.12–14  
B12r’s structure and it’s affinity for CO are not the only similarities to hemoglobin.  As 
mentioned, spectral absorption properties of B12 molecules (porphyrin-like corrin rings) are 
similar to Hb molecules (containing four porphyrin rings), and analyzers used to measure oxygen 
saturation and concentrations of Hb forms are confounded by this spectral similarity.12,15  Raman 
spectroscopy techniques have been used to measure Hb forms as well as B12 moieties. Our 
earlier work indicates that some forms of Hb may be measureable in spite of B12 
interference.8,12,13   
Raman Spectroscopy 
 The Raman Effect shifts the energy of the light scattered from a molecule that has Raman 
active vibrational bonds. This is in contrast to Rayleigh scattering or reflection, where the energy 
being absorbed is the energy being emitted.  The change in energy is slight, but measurable with 
sensitive spectrometers.  For example, our study uses a 406.7 nm wavelength laser for the 
excitation energy.  Much of this energy is scattered by the blood being analyzed with no change 
in wavelength and remains 406.7 nm.  However, a tiny percentage of this light is scattered with 
different shifted wavelengths above and below 406.7 nm (termed stokes and anti-stokes).  These 
shifted wavelengths of light are unique to the material and give insight to the vibrational modes 
of the molecule’s bonds.  Two forms of the same molecule that differ in their molecular bonds 
can be distinguished by Raman spectroscopy.  Hemoglobin forms are good examples.   
Figure 2 depicts Raman spectra taken from oxygenated and deoxygenated blood.  Since blood 
contains a high concentration of Hb, the Raman spectra of hemoglobin is intense, and the two 
 6 
 
forms are readily distinguishable.  The most intense peak (tallest amplitude) in both Hb forms is 
referred to as the 𝑣4 (pronounced nu-four) band which is associated with heme-ligand binding.  
This band shifts frequencies depending on whether the heme ligand is bound or unbound, 
oxygenated or deoxygenated. This property has been used to quantify Hb characteristics such as 
oxygen saturation.16  The 𝑣4 band also shifts slightly depending on which ligand is bound to it, 
O2 or CO. Figure 3 shows Raman spectra of oxygenated blood and blood exposed to CO until 
>90% COHb levels were reached.  Depicted here are peaks related to either O2 or CO association 
with Hb.  In HbCO2, CO2 is not a heme-protein ligand, and the Raman spectrum of CO2 exposed 
hemoglobin resembles that of deoxygenated blood (deoxygenated with N2 gas). 
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Figure 2 – 407.6 nm Raman spectra of oxygenated hemoglobin (Red) and deoxygenated hemoglobin (black).  
 
 
Figure 3 – 406.7 nm Raman Spectra of Oxygenated Blood (top, black) and CO-Exposed Blood (>90% COHb, 
bottom, blue).  This figure depicts the major peaks of interest for this study.  Note the 𝒗10 band at 1640 is 
attenuated in CO Blood.  1373 and 1377 peaks represent the positions for the 𝒗4 band for CO and Oxy blood 
respectively.  The CO Blood spectrum shows the Fe-CO and FeC=O vibrational bonds. 
 
Cognitive Behavioral Tests 
Impairment in memory and cognitive abilities are associated with CO injury, and both 
manifest post exposure and after a delay with no symptoms.  In rats impariment has also been 
demonstrated with various CO injury protocols and with various behavioral tests such as radial 
arm mazes, Morris water mazes, and open field tests.3,17–22  In this study, the Morris Water Maze 
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(MWM) was chosen as a test for learning and use of working memory by the rat.  The MWM 
utilizes a pool in which the rat is placed.  A hidden and submerged platform is the rat’s only 
escape from the pool.  Escape is the key motivation, and various protocols can be used for 
repetitive exposures to the pool.  Rats use visual cues to remember the location of the hidden 
platform between trials.  This spatial memory is combined with adaptation induced by the 
protocol such as delays between trials and relocation of the hidden platform.  The MWM and 
protocol used is further described in the Methods section. 
Novel to CO injury testing is the Water T-Maze (WTM) which seems to be more sensitive 
than the MWM.23  Instead of a circular pool, the rat swims a T-shaped maze.  Starting from the 
stem of the T, they must swim to an escape platform located either in the left or right arm of the 
T.  Each trial has two swim runs, and the rat must remember the Non-Matching rule: the escape 
platform in the second swim is in the opposite arm found in the first swim.  The rat must use 
working memory to be successful in escaping.  This working memory is taxed by the protocol 
with increasing delays between swim runs.  The WTM is further described in the Methods 
section.  In this study, we explore the difference between Exposed and Unexposed groups in the 
WTM. 
Hypothesis and Objectives for Study 
The first part of this study uses Raman spectroscopy, and hypothesizes that as CO in CO-
poisoned blood is removed from plasma and intracellular fluid (within red blood cells) by B12r 
catalyzing it to CO2, a local pressure gradient promotes removal of CO from HbCO.  HbCO 
becomes deoxyhemoglobin (Hb) momentarily, and then it may form oxyhemoglobin (HbO2) 
with the O2 already present in the blood.  Our objective was to investigate the relationships 
between HbCO, HbO2, Hb, and B12r as CO poisoned blood is treated with B12r via an in vitro 
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circulating gas exchange system, and using Raman spectroscopy as the accurate measurement 
technique.  This includes qualitative and quantitative observations of the potential interference 
B12r may have with the Raman spectrum of hemoglobin, and how we may be able to use that 
interference to our advantage.   
Specifically: 
1. Is the quality of the Raman spectrum of hemoglobin with B12r presence unhindered 
enough to measure hemoglobin signals? 
2. Comparing the Raman spectrum of CO-poisoned treated and untreated blood, can a 
measurable difference be observed in COHb Raman signal reduction that shows the 
impact of B12r? 
3. Comparing the Raman spectrum of blood before and after B12r introduction, can the 
differences in the spectra be used to quantify B12r concentration in blood? 
 The second part of this study used behavioral tests and hypothesizes that with timely removal 
of CO in blood shortly after CO exposure, neurological sequelae is mitigated.  This study uses 
CO injury in rats followed by treatment and testing with cognitive behavior mazes to observe 
changes in the working memory of rats.  The Morris Water Maze (MWM) Delayed Placement to 
Position test is used.  In addition, an exploration of a Water T-Maze Delayed Non-Matching to 
Position test is explored. 
Specifically: 
1.  Using the a CO Injury Protocol and the MWM, can we detect a difference between 
Exposed, Exposed Treated, and Unexposed groups in MWM parameters that indicate 
cognitive impairment due to injury. 
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2. Is a sufficient difference in WTM performance detectable between exposed and 
unexposed groups of rats such that it may be used for future tests of CO injury?  
 11 
 
Materials and Methods 
Blood 
 Fresh whole human blood was obtained from anonymous donors via the VCU Health System 
Apheresis Clinic’s phlebotomy program.  Blood was restricted to non-sickle cell and non-HIV 
donors.  The blood was treated with 1000 units of Heparin per 100 ml of blood in sterile blood 
donation bags, stored in the laboratory refrigerator and used within 5 days.  Stored blood bags 
were turned over to unsettle blood daily and prior to use.  Prior to experiments, blood bags were 
brought to room temperature and filtered using transfusion lines with 100 um clot filters as a 
precaution against blood clots; little to no clotting was observed, and blood with significant 
clotting activity were discarded.  The ex-vivo blood was circulated in our unique gas-exchange 
system to obtain target COHb percent concentration levels (apparatus described below).  Blood 
samples were obtained from the experimental apparatus, and analyzed with one of two blood gas 
machines.  The Radiometer ™ ABL 800 clinical blood gas analyzer was available in the Sanger 
Hall facility where antidote preparation and initial blood preparation occurs. The Radiometer™ 
OSM3 research blood gas analyzer was available in the Oliver Hall facility where the Raman 
spectroscopy measurements were made.  The ABL 800 measures pO2, pCO2, %HbO2, %HbCO, 
%MetHb, pH, and O2 Content.  The OSM3 measures %HbO2, %HbCO, %MetHb and O2 
Content.  When possible, blood samples from the Raman spectroscopy facility were brought 
back to Sanger Hall for blood gas analysis via the ABL 800. 
Preparation of Reduced Hydroxocobalamin 
Hydroxocobalamin (OHCbl), or Vitamin B12, in powdered form and pharmaceutical grade 
buffered L-Ascorbic Acid (AA) were obtained from Sigma-Aldrich.   Both were refrigerated at 4 
⁰C and sealed away from light in brown glass bottles (from manufacturer) or in clear vials 
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wrapped in foil as needed.  The AA was also maintained in an O2 free environment, and diluted 
with normal saline.  The normal saline used was deoxygnated with several cycles of vacuum and 
N2 gas exposure, then stored in laboratory glass containers filled with N2. All mention of normal 
saline in this study will refer to this deoxygenated saline source unless otherwise noted. 
Anaerobic preparation of the antidote was in a room temperature, positive pressure, N2 glove 
box by mixing B12 with the AA in syringes, and taking the solution out of the glove box in the 
stoppered syringe with needle.  Great care was taken to ensure preparation and handling in an 
O2-devoid environment prior to use.  Target concentrations for most uses ranged from 1 mg of 
B12 per ml of blood to 10 mg/ml B12r/blood. 
Raman Spectroscopy System 
 The Raman appartus included: a 406.7 nm krypton laser excitation source (Coherent Saber), 
various optics to optimize the excitation beam onto the sample flowing through a capillary tube, 
more optics to collect the emission light, a spectrometer fitted with a 600 mm grating, and a 
CCD camera (Princeton Instruments Python CCD) connected to a computer running 
spectroscopy recording software (Princeton Instrument WinSpec32).  The excitation laser beam 
hits the flowing blood through the capillary tube orthogonal to the emission light being collected.  
The apparatus is mounted on a laboratory table along with the blood circulating systems 
described below.  The laser output power was 0.7 mW to 08 mW, but was attenuated by a neutral 
density filter to 0.07 mW or 0.08 mW prior to hitting the sample.  Spectra of hemoglobin was 
collected for 3 to 5 minutes (20 seconds exposures, for 9 to 15 exposures).  The low power 
ensured minimal effect of photolysis of CO and O2 from Hemoglobin. 
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Gas Exchange Systems 
Raman measurements were taken via three methods: blood circulating in a non-gas exchange 
setup or in a gas exchange setup (both described below), or via capillary tubes of non-flowing 
fluids.  The experiments occurred between 22 and 24 ⁰C.  The circulating system for blood 
minimized photolysis of the gases bound to hemoglobin, and ensured thorough mixing of B12r 
with blood. 
The non-gas exchange system (Figure 4 and Figure 5) used a peristaltic pump to facilitate the 
flow of blood through Tygon tubing and a capillary tube.  A syringe allowed volume changes to 
prevent pressure changes in the system.  The internal volume of the setup was 5 ml.  The syringe 
allowed for up to 8 ml; however, minimal fluid was used to prevent areas of stagnant blood.  
This non-gas exchange system observed anaerobic B12r effects on Hb with the trapped gases in 
blood with no or minimal gas-exchange, or respiration.  
 
Figure 4 - Non-Gas Exchange Circulating Apparatus 
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Figure 5 - Schematic of Non-Gas Exchange Apparatus 
 
The gas exchange setup (Figure 6 and Figure 7) used a Maquet™ QUADROX-ID Pediatric 
Oxygenator with Tygon™ tubing.  A shunt was made to divert a portion of the blood flow 
through smaller Tygon tubing and a capillary tube.  The Gas Out port was attached to tubing, the 
end of which was placed into a lab hood.  The Gas-In port was used to flow gases into the gas-
exchanger.  Air-tight syringes were used to inject 100% CO gas into the Gas-In ports until 
desired COHb levels were reached.  The gas ports were either left open to allow flow, or 
clamped to trap the gases in the Maquet unit as needed.  The circulating fluid volume of the 
system was approximately 135 ml. 
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Figure 6 - Gas-Exchanging Apparatus 
 
 
Figure 7 - Schematic of Gas Exchange Apparatus with Shunt 
 
The blood was sampled periodically for %COHb and %HbO2 concentration depending on the 
gas analyzer used, and sampled for Raman spectra.   
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Animals and Injury (CO and Air Insult) 
 All procedures followed the guidelines established in the Guide for the Care and Use of 
Laboratory Animals (U.S. Department of Health and Human Services) and were approved by the 
Institutional Animal Care and Use Committee of Virginia Commonwealth University (Protocol 
Number AD10000569).  Long Evans Rats (LE rats) and Sprague Dawley Rats (SD rats) were 
used in the neurological testing.  LE Rats were used in the Morris Water Maze test.  SD rats were 
used in T-Maze pilot testing.  Rats were obtained from Harlan Laboratories, Inc, and weighed 
211±6 grams (LE Rats) and 203±41 grams (SD Rats) upon arrival.  All rats were housed two per 
cage, and maintained by VCU Department of Animal Resources veterinarian staff.  Rats were 
acclimated and their weights were monitored for a minimum 5 days prior to insult with CO or 
with Medical Grade Air (Air) as the control.  During acclimation, rats were habituated to 
handling by experimenters.  Rats undergoing T-Maze tests were habituated to the T-Maze 
environment on Day 3, and trained starting on Day 4 post-delivery.  After insult animal weights 
were monitored for at least 3 days, and on each day of neurological behavior testing.  After 
behavior testing, rats were euthanized with an intra-peritoneal injection of Sodium Barbital and 
monitored until their heart beats were no longer detectable.  Rats from each group were 
randomly selected for brain histology comparisons for a separate study (results in progress as of 
this writing). 
 Rats were divided into Control, Exposed Treated, and Exposed Untreated groups.  Morris 
Water Maze rats underwent insult, and were tested in blocks of 12.  T-Maze Pilot rats were 
tested in three batches of 8 and 12.  Rats were exposed to either CO or Air in 2 L air-tight 
chambers at 0.5 L/min after an initial two minutes at 2 L/min.3,17,18,20,21  For the CO exposure, 
rats were exposed to CO at 2500 ppm for 60 min, and then at 6000 ppm for a maximum 10 min 
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or until the animal was no longer responsive to stimuli.  To decrease mortality, CO flow was 
interrupted for a few minutes with air as needed near the 60-minute point prior to the 6000 ppm 
exposure phase, but total exposure time was maintained at 60 minutes.  After insult rats were 
administered treatment per their group assignment. Treatment was given via intra-peritoneal 
injection. Rats were placed in a separate holding cage until they regained normal response to 
stimuli, and then placed into their primary housing cage thereafter. 
Morris Water Maze Behavioral Tests  
 In the Morris Water Maze (MWM) test, a platform was submerged in a 1.8 m diameter pool 
filled with water to approximately 0.5 m. An escape platform was submerged 2 – 2.5 cm below 
the surface of the water.  The water was made opaque with white paint so that the platform was 
not visible, and the temperature was maintained between 25-27 degrees Celsius with a heat 
exchange pump.  The pump was removed during the swim trials.  There were 4 Stages of MWM 
testing. The location of the escape platform was changed each Stage as follows: Stage 1 in the 
NE Quadrant, Stage 2 in the NW Quadrant, Stage 3 in the SE Quadrant, and Stage 4 in the center 
of the pool.  A Stage of the MWM was conducted in a day.  Within each Stage rats performed 
four swim trials.  For each trial the start position of the swim was changed between North, South, 
East and West starting points.  Within each Stage, the start position was constant between Trials, 
and randomized between Stages.  The pool room had visual cues on the walls and other visual 
features that remained unchanged during the entire MWM experiments for consistent cues.  The 
rat was placed gently, keeping their heads from submerging, at the start position facing the wall; 
and the software tracking was started.  The AnyMaze™ system tracked the rat via a camera 
centered about 10 feet above the pool.  AnyMaze marks the end of the trial at 60 seconds or 
when the rat has successfully climbed onto the escape platform, whichever comes first.  The 
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software recorded escape latency and other parameters.  After each swim trial, the rat is placed 
into a holding cage under a heat lamp with towels for 10 minutes prior to the next swim trial.  LE 
Rats underwent MWM tests on Days 1, 3, 6 and 8 post-exposure; these days correspond to 
Stages 1 to 4 respectively.  The animal handler was blinded to the treatment group assignments.   
An independent reviewer watched the video recordings of the trials to correct automation 
recording errors.  The tracking software tracked the head of the animal rather than the body. At 
times, the rat’s head would stick out beyond the boundaries of the platform, and the tracking 
software would not mark a correct end-time.  The independent reviewer adjusted the Escape 
Latency times as necessary. 
Water T-Maze Behavioral Tests 
In the Delayed Non-Matching to Position (DNMP) Water T-maze the rat needs to learn to 
swim to the opposite platform from which it was previously informed (or forced) to go, and 
retain working memory of this rule with increasing delays between the information phase and the 
choice phase.  For example, in the “T” shaped maze where the base of the T is the start, a 
platform is located at the end of the right arm during the Information Phase, and passage to the 
left arm is blocked.  The rat is forced to swim to the right arm and find the platform and thus is 
informed of the platform and its location.  The rat is removed from the maze—this break from 
the T-maze is the Delay Phase and the Delay Time is a controlled variable. Passage to the left 
arm is cleared such that both arms are open, the right arm platform is removed, and a left arm 
(opposite side from first swim run) platform is inserted.  After the Delay Time passes, the rat is 
then placed back at the start.  A rat who has retained the rules of the test will swim to the left, or 
opposite, arm to find the platform versus the right as informed.  As Delay Time increases, the 
rat’s working memory is taxed, and failure to swim to the correct side increases. 
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The same pool and room from the MWM is filled with water and made opaque with non-toxic 
tempera paint and heated to 25-27 ⁰C; all visual cues were maintained consistent for all trials.  
Inside the pool a custom built T-Maze structure was placed and had slots for escape platforms at 
the end of the right and left arms, and a slide divider at the entrance to each arm to separate each 
arm independently from the central arm.  The T-Maze is submerged to a water level about 2 – 
2.5 cm above the escape platforms.  The start location for the rats was at the end of the central 
arm furthest from both platforms. 
Prior to injury, rats were habituated to the WTM by freely wading through the maze from the 
start location to one of the platforms at a water depth where they could still walk on all four legs; 
during habituation day, the water level was increased until they were forced to swim by the last 
trial.  Partitions were never placed to block the arms.  The goal during habituation is for the rat to 
be familiar with the T-Maze and most importantly, realize that there are platforms for escape.  
Handlers encouraged the rats to find both platforms. Rats are removed from the maze only via 
the platform to enforce the need to find the platform.  Rats perform this swim 10 times on 
Habituation Day.  Prior to Injury, rats were trained the rules of the Water T-Maze during 
Acquisition Days.  The goal during Acquisition Days was for each rat to learn the rules of the 
DNMP test. There were three phases to each trial: 1) Forced (or Information) – a divider will be 
place in one arm (the Forced Arm) forcing the rat to swim to the platform in that arm; 2) Delay – 
rats will rest for 7s – 10s in pool-side holding box while observer sets up for the next swim; 3) 
Choice – dividers are removed and platform from Forced phase is removed, leaving only a 
platform in the Forced Arm.  The arm opposite the Force Arm is the Choice Arm.  Forced 
direction was randomized and pre-determined prior to trials with no more than 2 consecutive 
trials in the same direction (example: R, R,L, L, R, L, L, R, R, L).  Work was conducted in 
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groups of 3 to 4 rats to ensure at least 4 – 5 minutes of rest between trials per rat.  Entering the 
Forced Arm was considered “Incorrect.”  If the rat entered the Force Arm, the divider placed to 
trap the rat in that arm.  This was the punishment for the wrong choice, and the rat would be 
forced to swim in the trapped arm for 10 sec after which the divider was removed to allow the rat 
to find the platform in the Choice Arm.  The rat was removed only after it firmly finds the 
platform.  Entering the Choice Arm was considered “Correct.”  If the rat entered the Choice 
Arm, it was removed immediately after it climbed onto the escape platform and then it was 
placed in the holding cage to dry and rest.  Post injury days utilized increasing delay times 
between the Forced and Choice swims to tax the animals’ working memory.  SD rats were used 
for the pilots and were separated in to Exposed and Unexposed groups. 
Analysis and Statistics  
 For the MWM studies, histogram plots are presented for visual and exploratory purposes.  
Statistical analyses were conducted in JMP Pro v10 software, or Microsoft Excel for simple 
means and standard deviations.  The MWM subjects were divided into three primary treatment 
groups: Unexposed, Exposed + Saline Treatment, and Exposed + B12r.  Predictor factors are as 
follows: subjects, trials, stages, and treatment.  The trials are nested factors within stages.  The 
most important response factor was escape latency, and a mixed model time-to-event analysis 
(Proportional Hazards Model) was conducted due to the upper time limit of the trials.  Mean 
speed response factor checked for motor skills differences, and a repeated measure analysis of 
variance was conducted for this factor. 
 Two WTM pilots with SD Rats were conducted.  Each pilot had two groups: exposed and 
unexposed.  Predictor factors were: subject, treatment, and delay.  The response factor is score.  
Post-injury scores were subtracted from Pre-injury scores to normalize the results.  Line plots of 
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mean and standard error were presented for visual and exploratory purposes, and non-parametric 
T-tests were conducted at each delay. 
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Results 
Preparation of Reduced Hydroxocobalamin 
For the reduction of B12r, various AA:B12 mass ratios were explored from 1:1 to 0.08:1. 
Molar calculations showed that to completely reduce B12 to B12r, a 0.08:1 mass ratio was 
sufficient; however, analysis with Raman spectroscopy showed significant signals for B12 and 
weak B12r signals in the 0.08:1 solution produced (Figure 8, second spectrum from top).  The 
1:1 mixture showed a Raman spectra with strong B12r signals and undetectable B12 signals from 
the raw spectrum; therefore, to demonstrate proof of concept, the 1:1 mixture was chosen in the 
Raman spectroscopy studies.  Since the Raman studies occurred after the MWM studies, the 
B12r used in the MWM used the calculated mass ratio of 0.08:1 AA to B12.  For the Raman 
studies, a 1:1 mass ratio was used; as an example, if “10 mg B12r” is stated, it means 10 mg B12 
mixed with 10 mg AA.  Fine tuning the formula and optimal B12 reduction methodology may be 
explored in later research. 
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Figure 8 - Raman spectrum of B12:B12r mixtures with Rel Raman (cm-1) on the horizontal and arbitrary 
intensity on the vertical axis.  As increasing amounts of AA are added to B12 (keeping B12 concentration 
constant), the B12 Raman Signal (top) decreases in intensity and B12r Raman Signal (bottom) is more 
pronounced.  Prominent peaks that identify each chemical have been labeled.12,13 
 
Raman Spectroscopy of Hemoglobin Changes 
 Figure 9 to Figure 11 below shows Raman spectra of poisoned blood being exposed to 100% 
O2 in the Maquet oxygenator. Figure 9 is the spectra from frequencies between 400 and 2000, 
and Figure 10 is the same but zoomed in between 1350 and 1400.  Figure 9 shows a visual 
decrease in peak heights for COHb (505 and 1950) as blood decreases from 74.3% COHb to 
12.1% COHb over 60 minutes while exposed to a flow of 100% O2.  In addition, the figure 
shows an increase in the HbO2 related peak at 1640 as %COHb decreases. Figure 10 is a zoomed 
in view between 1350 and 1400 frequencies and shows the drift of the 𝑣4 band from its known 
COHb position to its known HbO2 position.  Figure 11 shows the relationship between the 
Raman peak height changes at 505 and OSM3 measured %COHb.  Both the 505-peak height 
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changes and the 𝑣4 band movement from 1373 to 1377 can be use to measure %COHb via 
Raman.  At 12.1% COHb, the 𝑣4 band is solidly in the HbO2 position at 1377. 
 
Figure 9 – Oxygen only treatment of poisoned blood.  Transitioning Raman spectra of Hb from 74% COHb 
to 12% COHb (top to bottom).  Arbitrary Intensity on the Vertical Axis. 
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Figure 10 - Oxygen only treatment of poisoned blood.  Transitioning Raman spectra of Hb from 74% COHb 
to 12% COHb (top to bottom) zoomed in on the 𝒗4 bands (1350 – 1400 frequencies). Arbitrary Intensity on 
the Vertical Axis. 
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Figure 11 - Plot of Raman Peak 505 Height vs %COHb.  Poisoned Blood (74% COHb) treated with a flow of 
100% O2 
Figure 12, Figure 13 and Figure 14 below show a repeat of the above experiment but 
adding 250 mg of B12r (2 mg of B12r per ml of blood).  The same blood was used and re-
exposed to CO until 89% COHb was reach (marked as T = 0).  Despite the interference from 
B12r, the same changes can be observed in the Raman spectra.  Except for the pre-B12r sample, 
there is no measurement of %COHb; the OSM3 displayed error warnings with all values due to 
the B12r presence.  The 𝑣4 band is solidly at the 1377 HbO2 position at T = 55 min, and this may 
be associated with a COHb percentage of about 12% based on the proceeding results.  Figure 14 
shows a comparison between O2 and O2+B12r treatments in this oxygenation experiment.  
Coupled with Figure 13, Peak-505 height measurements versus time show an advantage of the 
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O2+B12r treatment to reduce the COHb signal to baseline; the 𝑣4 band position (Figure 13) 
confirms a strong HbO2 signal has been reached.  This occurs at about the 55 min point for the 
O2 + B12r experiment while with the O2 only trial, it occurs at 112 minutes. 
 
Figure 12 - B12r+O2 on Blood.  Transitioning Raman spectra of Hb from 89% COHb to an equivalent 12% 
COHb (top to bottom). 
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Figure 13 - B12r+O2 on Blood.  Transitioning Raman spectra of Hb from 89% COHb to an equivalent 12% 
COHb (top to bottom) focusing on the 𝒗4 band. 
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Figure 14 - Peak-505 Height Changes over Time for both O2 and O2+B12r Treatments.  O2 treatment started 
at 74% COHb and the O2+B12r treatment started at 89%COHb.  Raman sampling stopped when Peak 505 
became indistinguishable from background (112min for O2, 65min for O2+B12r). 
 
 The below three figures show changes in the Raman intensity of the 1373 frequency peak due 
to the B12r’s presence.  Here we try to find an exploitable relationship between changes in the 
Raman spectrum and the concentration of B12r used.  The non-gas exchange apparatus was used 
to minimize/slow down changes in COHb concentration.  Relative height of the 1373 peak is 
used: height of 1373 (affected by B12r) is subtracted from the height of peak 1430 (not affected 
by B12r).  Figure 16 shows a pre and post B12r spectrum of the 𝑣4 band. Peak height of the band 
will be taken relative to the 1430 peak (subtracting the height of 1430 from 𝑣4). 
0
1000
2000
3000
4000
5000
6000
0 20 40 60 80 100 120
Pe
ak
 5
0
5
 R
el
 H
ei
gh
t,
 A
rb
it
ra
ry
 U
n
it
s
Time (min)
O2 vs O2+B12r Treatments of CO Poisoned Blood
Height Changes Over Time
O2 Only O2 + B12r
 30 
 
 
Figure 15 - Effect of B12r on Raman Signals of CO-Exposed Blood. 
 Figure 16 and Table 1 include data from another pre/post blood sample measurements at high 
COHb concentrations but with varying concentrations of B12r used.  The plot indicates a 
relationship that can be used to instrument Raman for B12r measurements alongside Hb form 
measurements upon treatment. 
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Figure 16 - Relationship between Raman Peak Height at 1373 (normalized to peak height at 1430) vs B12r 
Concentration in Blood. 
Table 1- Table of Data Used in Figure 16 
 
 
 
Figure 17 and Figure 18 show mixing of B12r with either Oxygenated Blood or CO-Exposed 
blood in the non-gas exchange circulator. Figure 17 results show Deoxy formation immediately 
after B12r introduction.  However, after 10 minutes of circulating in the non-gas exchange 
system, a slow return to an Oxy spectrum started, and cumulated in a near return to the original 
spectrum after 25 minutes. A spectrum of Deoxy-blood is placed in this figure for reference 
(obtained several days later using N2 exposed blood). The Post-B12r Oxy-blood spectrum is 
practically identical to Deoxy.  Figure 18 shows no change in the CO Blood spectrum post B12r 
mixing; however, the blood was poisoned to a high level of CO (89.9% COHb).  The 250 mg of 
B12r used was insufficient for such a high amount of CO molecules. 
%COHb
B12r
(mg per ml of Blood)
Rel Pk Ht 
Change 
(%)
87.5 0 0
89.9 2 17
87.6 5 23
87.4 10 26
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Figure 17 - Anaerobic Mixing of B12r with Oxygenated Blood.  From Bottom to Top, Oxygenated Blood 
(99% O2Sat), 1 minute after B12r mixing, and (Top) a reference spectrum of Deoxygenated Blood. 
 
Figure 18 - Anaerobic mixing of B12r with CO-Exposed Blood (97% COHb).  From the bottom: CO Blood 
Pre-B12r, CO Blood 2 min Post-B12r, 30min Post B12r, and (Top) 60min Post B12r. 
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Animal Manipulations 
 Rat behavior was unaltered during the first 30 minutes of exposure at 2500 ppm.  Between 30 
and 45 minutes rats exhibited lethargy, but still reacted to stimuli: sharply tapping on the 
exposure chamber wall would cause their ears to twitch and their heads oriented towards the 
noise.  Between 45 and 60 minutes there was decreased reaction to stimuli: head orientation 
decreased or was slow, but ear twitching response was still immediate.  After the 60-minute 
mark, the transition from 2500 ppm to 6000 ppm CO, animals became agitated and large 
movements were observed for 1 – 2 minutes: 180 degree body reorientations, deeper and/or 
increased breathing.  Gradually, response to stimuli decreased, and the large movements 
desisted. Sharp tapping or jostling of their chamber was used to test for syncope. Most rats 
needed to be evacuated from their chamber before the 10 minute exposure period ended. A few 
rats ceased breathing and died. One rat died during post-exposure recovery. This injury protocol 
resulted in a 14.7% mortality. 
Morris Water Maze 
 Figure 19 below shows the histogram plots of the MWM Escape Latency times by trial and by 
stage showing learning and memory usage of the Unexposed, Exposed + Saline, and Exposed + 
B12r groups as a single population. Stage Day 1, Trial 1 (one day post exposure) is the first 
exposure to the pool and therefore rats finding the escape platform on this trial is by chance, or if 
they reach the 60-minute time limit, they are lead to the platform.  This is reflected by the 
flatness in the histogram for Trial 1.  During this first trial, rats tended to swim mostly at the pool 
perimeter, trying to find purchase on the pool walls.  Subsequent trials show increasing 
improvement.  On Stage Day 1, Escape Latency decreases progressively from Trial 2 to Trial 4 
showing that rats are acquiring the set of behaviors to escape more quickly – understanding that 
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there is an escape platform, and remembering its location.  Stage Day 3 & Day 6 show a stark 
difference from Stage Day 1.  Stage Day 4 show a slight regression in Escape Latency as the 
platform location is no longer in a quadrant, but was moved to the center of the pool. 
 
            
Figure 19 – Histograms of Unexposed, Exposed + Saline and Exposed + B12r rats as a single population with 
Escape Latency times represented in histogram.  Left histograms of trials are for all stages and show 
increasing proficiency from Trial 1 to Trial 4.  Right histogram of stages are for all trials and show MWM 
rule learning improvement from Stage Day to Stage Day 8. 
 
 Analysis of the Escape Latency factor showed no significant escape probability differences 
between Unexposed, Exposed + Saline, and Exposed + B12r groups.  The probability of an 
Unexposed rat escaping the MWM versus an Exposed + Saline rat was 1.04 to 1 with a 95% 
Confidence Interval (C.I.) of [0.85, 1.27].  The probability of an Exposed+B12r rat escaping the 
MWM versus an Exposed + Saline rat was 1.05 to 1 (95% C.I. of [0.89, 1.25]).  The probability 
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of an Exposed+B12r rat escaping the MWM over an Unexposed rat was 1.05 to 1 (95% C.I. of 
[0.84, 1.23]). 
 The analysis of the mean speed (p-value = 0.1162, DF=5, F-Ratio=1.7692) factor showed no 
significant differences between Unexposed, Exposed+Saline and Exposed+B12r. 
Water T-Maze Pilots 
 The Water T-Maze Pilots showed no statistically significant differences between Exposed and 
Unexposed rats.  Figure 20 and Figure 21 show a separation of means at certain post-injury 
events.  However, the separations were not significant.  The data showed high variability 
between subjects.  Figure 20 shows a potential to differentiate between Unexposed and Exposed 
CO-Injured rats for next day neurological sequelae but not for delayed neurological sequelae.  
Additionally, the difference needed to insert a treatment group, however, may not be enough.  
Statistical comparison by Repeated Measures ANOVA Student’s t results in a non-significant 
difference between Expose and Unexposed of: Difference = 0.064%, p-value = 0.1588, 95% C.I. 
of [-0.026, 0.154].  Figure 21 also shows a separation in the first two days post injury, and also 
20 days later, but neither were statistically significant. 
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Figure 20 - Percent Correct Mean Plot +/- S.E. of the First Pilot for the Water T-Maze. N=3 for each group.  
Normalized at Pre-Injury by subtracting scores to result in 60% correct for all rats.  Post1 – Post6 are post 
injury tests, and Delay 1 & 2 are tests delayed to Days 20 and 21.   
 
Figure 21 - Percent Correct Mean Plot +/- S.E. of the Second Pilot for the Water T-Maze.  Normalized at Pre-
Injury by subtracting scores to result in 70% correct for all rats.  Reacquistion occurred at 20 days post-
injury.   
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Discussion 
Raman Analysis of COHb Changes with Antidote 
Our in vitro experiments showed COHb levels reduced by 77 percentage points in 55 minutes 
with B12r + O2.  This shows a large improvement over the O2-only trial that reduced COHb 
levels by 62 percentage points in 112 minutes.  The two trials used the same blood donor. During 
the O2-only trial, blood samples were taken, but only an initial blood sample was taken in the 
B12r + O2 trial.  Collection of the Raman spectrum was therefore easier which is why there are 
more data points in the B12r + O2 trial.  We don’t believe this difference in collection frequency 
affects the results.  This experiment gives evidence that answer our objectives in using Raman to 
detect Hb changes with B12r, and that B12r may indeed provide a faster clearance of CO from 
poisoned blood.  More paired trials are needed between O2-only and B12r + O2 treatments.  The 
Maquet™ system proved to be an extremely efficient gas-exchange device.  Administration of 
100% O2 via the Maquet oxygenator may be too strong of an influence in this in vitro set up and 
may wash out the effects of B12r.  In humans administration of 100% O2 has clearance 
expectations of up to 6 hours for non-fatal CO exposures (20-30% COHb).5  This is a wide range 
due to human variability, but at the slow end, a 20% point reduction in six hours seems to be a 
plausible expectation in vivo. Repeating this experiment with air instead of 100% O2 may better 
demonstrate the efficacy of B12r. 
The non-gas exchange trials of COHb mixed with B12r allowed us to observe relationships 
between the B12r interference on the Raman spectra of Hb.  As observed in Figure 15, 𝑣4 band’s 
relative intensity drops with addition of B12r in the blood.  This may be attributed to excitation 
energy absorption by the B12r as well as the absorption of the emitted energies of the Raman 
shifted light. The absorption would be in line with the Beer-Lambert law, that absorption of 
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specific energies of light has a predictable absorption profile proportional to concentration.  An 
exploitable relationship exists with dual absorption, and more trials are needed to narrow down 
the model.  The 407.6nm excitation energy is being absorbed and thus does not excite the 
molecular bonds as much.  The second absorption event is on the light emitted from the 
vibrational bonds, and each peak has a different absorption profile since it is a different 
wavelength than the excitation source. For example, the 505 peak is due to emission of a 415nm 
light, and the 1950 peak is a 441nm wavelength emission.  In this thesis, we have not completely 
satisfied our objective to quantify B12r concentration in blood; though a relationship is evident. 
Absorption profiles for B12r and the excitation laser could potentially be used in a mathematical 
model to measure B12r concentration. 
The non-gas exchange experiment also produced some results that were unanticipated.  Figure 
17 shows the complete switch from an oxygenated blood spectrum to a deoxygenated blood 
spectrum by introduction of B12r into oxygenated blood.  Some preliminary investigation has 
already been done that is not included in this thesis. B12r appears to be making sufficient 
changes to pH causing a lower affinity of Hb to O2. There is also a compound effect from CO 
and CO2. The presence of CO causes a higher affinity of Hb to O2, and CO2 causes a lower 
affinity of Hb to O2. Therefore, when the B12r causes CO to catalyze to CO2, and reversal in O2 
affinity may be the cause of this drastic conversion to DexoyHb. Additionally, O2 might be 
affected by B12r directly as we are using B12r to mimic hemoglobin’s affinity for CO. It is 
plausible that B12r may have an affinity for O2. Future biochemical studies will be beneficial to 
measure affinities of B12r to both CO and O2. 
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Behavioral Trials 
Although modeled after previous work in which differences were found between CO-injured 
rats and uninjured rats in a MWM test, our modifications produced no significant differences that 
can be interpreted from the odds of escape between Unexposed, Exposed+Saline and 
Exposed+B12r groups.21  The Time-to-Event statistical method chosen in this study is different 
from the repeated measures analysis of variance typically chosen; however, performing repeated 
measures ANOVA (F2, 830 = 0.6546, p-value = 0.5199) also show no statistical significance.  The 
exposure protocol used by Sun et al exposed Sprague Dawley rats to 1000 ppm of CO for 40 min 
followed by up to 20 min of 3000 ppm CO or until the animal fainted.21  There are various other 
injury protocols as well.  One showed that 2500 ppm CO exposure for 60 min may not produce 
syncope, but resulted in some syncope and deaths after 75 min in one study; and in another 
study, 3000 ppm for a little greater than 60 min produced some deaths.17,18  The decision to 
increase the concentrations used to 2500 ppm for 60 min, followed by 6000 ppm for up to 10 
min or until syncope stemmed from the need to ensure exposure while keeping mortality rate 
low. The CO-injury appeared sufficient since we observed syncope in most subjects as well as 
observed a 14.7% mortality.  The Long-Evans strain used is not novel in carbon monoxide 
studies with neurocognitive tests, and some have even used Wistar and Fisher Inbred 
strains.3,17,20  But the only studies that have used the MWM with carbon monoxide poisoning 
used the Sprague-Dawley strain.21,22,24  Selection of the Long-Evans strain may be a minor factor 
for the differences in outcome. 
The MWM can be conducted with differing protocols, and here is where the main difference 
lies between this study and some of the literature guides for MWM on CO Injury.  The place-
navigation protocol used in literature was pilot tested prior to our study, and we found no 
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significant difference between exposed and unexposed rats.  The place-navigation protocol 
involved finding the hidden escape platform from varying starting compass points (north, south, 
east or west) in the pool; and the platform location was fixed—never relocated between trials or 
between stages.21,25  This task of remembering a fixed though hidden location seemed too 
simplistic.  We modified the protocol to stress working memory using a delayed matching to 
place protocol as described in the methods section, and we were encourage with early trends, but 
in the end, no differences could be found. 
After the results of the MWM, we sought another cognitive behavioral test for CO Injury.  
Experts at VCU indicated that finding an appropriate test can be a trial-and-error experience.  
The WTM to our knowledge has not been used with a CO injury model, but was successfully 
used in traumatic brain injury experiments with rats.  It was also an attractive option due to the 
availability of a T-Maze that can be borrowed to place into the MWM pool, and therefore, a 
quick set-up.  Our pilot results were more promising than the MWM results to differentiate 
between Exposed and Unexposed SD Rats.  There were trends of separation between the groups 
despite no significance.  However, the variability of scores from the rats was high, and the 
numbers, time, and resources for a sufficiently powered study would have been too great. 
We harvested and stored brain samples of the rats from both studies.  Per literature, the cortex, 
hippocampus and basal ganglia regions of rats injured with CO exposure show increased neural 
cell damage and/or death as well as increased microglial activation.18,19,21,26  Our future histology 
studies will verify brain injury by our CO injury model.  We may also be able to identify rats that 
were exposed to CO but due to susceptibility, may not have been injured sufficiently and re-
analyze the MWM and WTM data.  Preliminary H&E stains show new vascular growth in the 
brains of our CO exposed subjects versus normal vasculature in unexposed rats which indicates 
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that injury was occurring.  The injury protocol was the same for the Long Evans rats used in the 
MWM and the Sprague Dawley rats used in the WTM.  The future pathohistology results we 
obtain may shed light on strain differences of CO injury. 
For this second part of the study, we could not meet the objectives due to the inability to 
differentiate between control subjects and injured subjects. For future studies, a radial arm maze 
might be another option to explore since this has been used in CO injury experiments using rats.  
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Summary 
Our aim to develop a novel treatment for victims of CO poisoning is highly applicable to 
public health concerns.  In addition to the 15,000 non-fire CO exposures reported annually, there 
were over 500,000 structure fires in 2000.27  A field administered, quick-acting treatment would 
be of tremendous value.  Our previous work in the lab gave us an indication that this can be done 
with human blood by measuring CO2 generation in an in vitro bench top study of B12r treated 
blood.8  Our present work has given us further insight into B12r’s action with human blood and 
has raised further questions to answer.  B12r treatment coupled with the current treatment of 
100% O2 can greatly enhance removal of CO. We find that the O2 treatment is also critical as the 
B12r affects HbO2 if not O2 directly. We show that Raman spectroscopy is a potential method to 
study Hb forms even with the interference of B12r. This technology to measure B12r 
concentration alongside concentrations of Hb forms in human blood with a B12 presence can 
already be valuable for victims of cyanide poisoning since Cyanokit™, a B12 intravenous 
treatment, muddles clinical diagnostics machines using absorbance spectroscopy.  Future work 
here is the natural progression to in vivo experimentation with a micro-circulation Raman 
spectroscopy system with small animal models for CO injury and treatment with B12r, and 
further studies with robust computations to measure B12r in blood using combine Raman and 
absorbance spectroscopy. Concurrently, studies to find a reliable model for testing neurological 
sequelae in CO injury is necessary. The rat species may not be the most appropriate since the 
cognitive impairment in humans is often at higher levels of reasoning and operation.    
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